ATE387442T1 - Verfahren zur herstellung einer östrogenzubereitung und aus einer pflanze isolierte östrogenverbindungen und deren anwendungen - Google Patents

Verfahren zur herstellung einer östrogenzubereitung und aus einer pflanze isolierte östrogenverbindungen und deren anwendungen

Info

Publication number
ATE387442T1
ATE387442T1 AT02786342T AT02786342T ATE387442T1 AT E387442 T1 ATE387442 T1 AT E387442T1 AT 02786342 T AT02786342 T AT 02786342T AT 02786342 T AT02786342 T AT 02786342T AT E387442 T1 ATE387442 T1 AT E387442T1
Authority
AT
Austria
Prior art keywords
estrogen
plant
applications
producing
preparation
Prior art date
Application number
AT02786342T
Other languages
English (en)
Inventor
Eu Leong Yong
Sook Peng Yap
Original Assignee
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Singapore filed Critical Univ Singapore
Application granted granted Critical
Publication of ATE387442T1 publication Critical patent/ATE387442T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02786342T 2001-11-09 2002-11-08 Verfahren zur herstellung einer östrogenzubereitung und aus einer pflanze isolierte östrogenverbindungen und deren anwendungen ATE387442T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33118301P 2001-11-09 2001-11-09

Publications (1)

Publication Number Publication Date
ATE387442T1 true ATE387442T1 (de) 2008-03-15

Family

ID=23292928

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02786342T ATE387442T1 (de) 2001-11-09 2002-11-08 Verfahren zur herstellung einer östrogenzubereitung und aus einer pflanze isolierte östrogenverbindungen und deren anwendungen

Country Status (7)

Country Link
US (1) US6750248B2 (de)
EP (1) EP1453827B1 (de)
AT (1) ATE387442T1 (de)
DE (1) DE60225323T2 (de)
ES (1) ES2302858T3 (de)
PT (1) PT1453827E (de)
WO (1) WO2003040134A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1194702C (zh) 2002-12-18 2005-03-30 澳美制药厂有限公司 治疗前列腺肥大的淫羊藿提取物及其在制备药物中的应用
US8668908B2 (en) * 2002-12-31 2014-03-11 National Yang-Ming University Method for alleviating chemotherapy side effects using extract of Dioscorea sp
US20040126447A1 (en) * 2002-12-31 2004-07-01 Rong-Tsun Wu Extract of Dioscorea sp. and the medical uses thereof
US20060068036A1 (en) * 2002-12-31 2006-03-30 National Yang-Ming University Extract of Dioscorea sp. and the medical uses thereof
US7465739B2 (en) * 2003-06-10 2008-12-16 Solvay Pharmaceuticals B.V. Compounds and their use in therapy
US7754709B2 (en) * 2003-06-10 2010-07-13 Solvay Pharmaceuticals Bv Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
US8088758B2 (en) * 2003-11-12 2012-01-03 Abbott Products Gmbh 17β-hydroxysteroid dehydrogenase type I inhibitors
JP2006146490A (ja) * 2004-11-18 2006-06-08 Ricoh Co Ltd 印刷制御装置及び印刷制御プログラム
AU2005316824B2 (en) * 2004-12-17 2012-05-31 Bionovo, Inc. Method of using extracts of epimedium species
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7563464B1 (en) 2005-04-22 2009-07-21 Bruce Eric Hudkins Treatment of mucosal membranes utilizing phytoestrogen
US20060251749A1 (en) 2005-05-09 2006-11-09 Unigen Pharmaceuticals, Inc. Compositions Of Bakuchiol And Methods Of Making The Same
US8030298B2 (en) * 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
EP1904075A2 (de) * 2005-07-15 2008-04-02 Dr. Willmar Schwabe GmbH & Co. KG Extrakte aus epimedium-arten, verfahren zu ihrer herstellung und verwendung
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
US8080540B2 (en) * 2006-09-19 2011-12-20 Abbott Products Gmbh Therapeutically active triazoles and their use
CN101528038B (zh) * 2006-10-25 2011-05-11 盛诺基医药科技有限公司 用于治疗与雌激素受体相关的疾病的化合物和方法
US8288367B2 (en) * 2006-11-30 2012-10-16 Solvay Pharmaceuticals Gmbh Substituted estratriene derivatives as 17BETA HSD inhibitors
CN101244074A (zh) * 2007-02-16 2008-08-20 首都医科大学宣武医院 淫羊藿黄酮及其有效成分在制备促进神经细胞增殖和分化作用药物中的用途
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
AU2008285325A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of Ligustrum lucidum and uses thereof
JP2010539085A (ja) * 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのキバナオウギのエストロゲン性抽出物およびその使用
US9155770B2 (en) * 2007-09-07 2015-10-13 Bionovo, Inc. Estrogenic extracts of Scuttelaria barbata D. don of the labiatae family and uses thereof
AU2008296176A1 (en) 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Asparagus conchinchinensis (Lour.) Merr of the Liliaceae Family and uses thereof
AU2008296076A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Pueraria lobata Willd, Ohwi of the Leguminosae family and uses thereof
US7879369B2 (en) * 2007-09-18 2011-02-01 Selvamedica, Llc Combretum laurifolium Mart. extract and methods of extracting and using such extract
WO2009067555A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
AU2008326426A1 (en) 2007-11-19 2009-05-28 Bionovo, Inc. Methods of detecting and treatment of cancers using scuttelaria barbata extract
WO2009070478A2 (en) 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
WO2009067553A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
WO2009126923A2 (en) * 2008-04-11 2009-10-15 Bionovo, Inc. Estrogenic extracts of anemarrhena asphodeloides bge from the liliaceae family and uses thereof
AU2009236339A1 (en) * 2008-04-14 2009-10-22 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
JP2011519947A (ja) * 2008-05-06 2011-07-14 バイオノボ・インコーポレーテッド 膣および外陰の委縮を治療するために使用するエストロゲン様抽出物
CA2726982A1 (en) * 2008-06-05 2009-12-10 Bionovo, Inc. Method of quantification of multiple bioactives from botanical compositions
WO2009148620A2 (en) * 2008-06-06 2009-12-10 Bionovo, Inc. Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
CN101607976B (zh) * 2008-06-19 2013-09-04 贵州省中国科学院天然产物化学重点实验室 一种淫羊藿苷的制备方法
CA2734523A1 (en) * 2008-09-03 2010-03-11 Bionovo, Inc. Methods and compositions for the treatment of cancer
US20100303936A1 (en) * 2009-04-28 2010-12-02 Bionovo, Inc. A Delaware Corporation Method of reducing fat accumulation and inducing weight loss
CN103965172A (zh) * 2009-09-11 2014-08-06 盛诺基医药科技有限公司 治疗雌激素受体相关疾病的化合物及其方法
US9713596B2 (en) 2011-02-02 2017-07-25 Unigen, Inc. Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
WO2013023617A1 (en) * 2011-08-17 2013-02-21 The University Of Hong Kong Novel bioactive protein isolated fron chinese yam and uses thereof
CN102973659A (zh) * 2011-09-05 2013-03-20 首都医科大学 一种防治糖皮质激素性骨质疏松症的中药小复方及其制备方法
US9663549B2 (en) 2013-06-25 2017-05-30 Forendo Pharma Ltd. Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase
JP6461127B2 (ja) 2013-06-25 2019-01-30 フォレンド ファーマ リミテッド １７βヒドロキシステロイド脱水素酵素、タイプＩの阻害剤としての治療活性エストラトリエンチアゾール誘導体
CN105518017B (zh) 2013-06-25 2020-07-14 佛恩多制药有限公司 治疗活性的作为1型17β-羟基类固醇脱氢酶抑制剂的雌三烯噻唑衍生物
WO2016102776A1 (en) 2014-12-23 2016-06-30 Forendo Pharma Ltd Prodrugs of 17.beta.-hsd1 -inhibitors
JP6545266B2 (ja) 2014-12-23 2019-07-17 フォレンド ファーマ リミテッド １７β‐ＨＳＤ１抑制剤のプロドラッグ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874084A (en) 1996-07-19 1999-02-23 Yng-Wong; Quing Non Using complex herbal formulations to treat hot flashes
US6123944A (en) 1998-03-19 2000-09-26 Phytoceutica, Inc. Icariin preparations
US6071883A (en) 1998-07-28 2000-06-06 Chen; Huifang Flavone analogues useful as anti-rejection agents
AUPQ127399A0 (en) 1999-06-29 1999-07-22 Guangzhou University Of Traditional Chinese Medicine Compositions and methods for treating or preventing osteoporosis
US6238707B1 (en) 2000-10-11 2001-05-29 Zhang Chun Herbal hormone balance composition

Also Published As

Publication number Publication date
EP1453827A4 (de) 2005-02-23
EP1453827B1 (de) 2008-02-27
ES2302858T3 (es) 2008-08-01
DE60225323D1 (de) 2008-04-10
DE60225323T2 (de) 2008-10-30
PT1453827E (pt) 2008-06-02
US20030170292A1 (en) 2003-09-11
WO2003040134A9 (en) 2004-03-25
WO2003040134A1 (en) 2003-05-15
EP1453827A1 (de) 2004-09-08
US6750248B2 (en) 2004-06-15

Similar Documents

Publication Publication Date Title
ATE387442T1 (de) Verfahren zur herstellung einer östrogenzubereitung und aus einer pflanze isolierte östrogenverbindungen und deren anwendungen
ATE555833T1 (de) Verfahren zur zubereitung von angereicherten cannabinoid-extrakten aus cannabis- pflanzenmaterial
MY148081A (en) Cultivated agarwood
ATE356084T1 (de) Verfahren zur herstellung eines silicoaluminophosphat-molekularsiebs
DE69711395T2 (de) Verfahren zur herstellung von cyclohexen-carboxylatderivate
ATE448698T1 (de) Verfahren zur extraktion von carotinoiden
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
DE60138804D1 (de) Verfahren zur herstellung von physiologisch aktiven substanzen enthaltenden dispersionen unter anwendung von hochdruck und hochscherkraft
ATE278390T1 (de) Verfahren zur herstellung von arzneistoffpartikeln
DE60124300D1 (de) Feinteiliges funktionelles metall und feinteiliger funktioneller halbleiter, die jeweils dispersionsstabilität aufweisen, und verfahren zur herstellung derselben
DE60316573D1 (de) Verfahren und vorrichtung für die herstellung einer ein bituminöses bindemittel enthaltenden baumischung
ATE257388T1 (de) Extrakte aus sophora-arten, verfahren zu ihrer herstellung und verwendung
DE60311990D1 (de) Verfahren zur herstellung eines virus inaktivierten thrombin präparates
ATE479332T1 (de) Verfahren zur hemmung der ethylenreaktionen von pflanzen
DE60124289D1 (de) Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op)
DE502007002510D1 (de) Keramische Einbettmasse zur Herstellung einer Giessform sowie damit verbundene Herstellungsverfahren
ATE424833T1 (de) Orale immunstimulierung von säugern, vögeln und reptilien durch (1-4)-verknüpfte beta-d- mannuronsäure
DE60001966D1 (de) Verfahren zur epoxidierung von substituierten cyclohexanonen
DE60114122D1 (de) Verfahren zur herstellung einer aus pflanzen stammenden, antibakteriellen substanz
DE69519203D1 (de) Verfahren zur Herstellung von Extrakten enthaltende polyphenalische oligomere Verbindungen von Catechin-Typ, aus pflanzenartigen Quellen, und diese erhaltene Extrakte
DE50103009D1 (de) Verfahren zur herstellung von 2-alkyl-3-chlorphenolen
ATE535538T1 (de) Verfahren zur herstellung von guggulsteronen und guggulsterol
ATE476548T1 (de) Antioxidationsmittel für organisches material und verfahren zur behandlung desselben
ATE344620T1 (de) Verfahren zur hemmung der ethylenreaktionen von pflanzen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1453827

Country of ref document: EP

REN Ceased due to non-payment of the annual fee